Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
  • India

    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

    Siddhant Pandey
    Written by
    Siddhant Pandey
    Twitter
    Last updated on Jan 05, 2021, 05:00 pm
    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
  • The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

    SII's Covishield and Bharat Biotech's COVAXIN had been granted emergency use authorization (EUA) for restricted use in India earlier on Sunday.

    On Monday, Prime Minister Narendra Modi said that India will soon start its vaccination drive.

  • In this article
    'Fully aware of importance of vaccines for people and countries' Companies to prioritize populations that need vaccine most How were the vaccines made? Both vaccines granted EUA on Sunday COVAXIN to be used as back-up, say AIIMS, ICMR heads COVAXIN not a back-up, says Bharat Biotech MD
  • Pledge

    'Fully aware of importance of vaccines for people and countries'

    'Fully aware of importance of vaccines for people and countries'
  • According to a statement, both SII CEO Adar Poonawalla and Bharat Biotech MD Krishna Ella communicated their intent to "develop, manufacture, and supply the COVID-19 vaccines for India and globally."

    "We are fully aware of the importance of vaccines for people and countries alike. We hereby communicate our joint pledge to provide global access for our COVID-19 vaccines," the statement added.

  • Pledge

    Companies to prioritize populations that need vaccine most

    Companies to prioritize populations that need vaccine most
  • The statement mentioned that the two companies are now focusing on the manufacture, supply, and distribution of the vaccines in a way that prioritizes populations that need them most.

    "Both our companies are fully engaged in this activity and consider it our duty to the nation and the world at large to ensure a smooth rollout of vaccines," it said.

  • Vaccines

    How were the vaccines made?

  • Covishield—developed by AstraZeneca and Oxford University and manufactured by SII—is a recombinant chimpanzee adenovirus vector vaccine encoding the SARS-CoV-2 spike protein. It has been found to have an overall efficacy of 70.42%.

    COVAXIN is an inactivated vaccine, i.e., it uses a killed version of the whole virus. Phase III trials are still underway, hence, Bharat Biotech is yet to submit efficacy data.

  • EUA

    Both vaccines granted EUA on Sunday

    Both vaccines granted EUA on Sunday
  • On Sunday, the Drugs Controller General of India (DCGI) Dr. VG Somani had announced that the two vaccines have been granted EUA.

    The emergency approval for COVAXIN has drawn criticism from independent experts due to the language used. The vaccine has been granted EUA "in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains."

  • Controversy

    COVAXIN to be used as back-up, say AIIMS, ICMR heads

    COVAXIN to be used as back-up, say AIIMS, ICMR heads
  • The language used for the EUA for COVAXIN has led many to believe that the vaccine has only been granted approval to be used as a "back-up," unlike SII's Covishield.

    The same was confirmed by members of the National COVID-19 Task Force—AIIMS Director Dr. Randeep Guleria and ICMR Director-General Dr. Balram Bhargava—who told The Indian Express that COVAXIN will be used as a back-up.

  • Information

    COVAXIN not a back-up, says Bharat Biotech MD

  • However, Ella has disputed the statement of the heads of AIIMS and ICMR regarding the vaccine being used as a back-up. He has also said that Bharat Biotech has "tremendous experience" in developing vaccines and their vaccine is "200% safe."

  • Narendra Modi
  • Oxford University
  • AIIMS
  • Randeep Guleria
  • Drugs Controller General of India
  •  
Latest News
  • Coronavirus: India's tally reaches 11.19 million with 18K+ new cases
    Coronavirus: India's tally reaches 11.19 million with 18K+ new cases
    India
  • Harry, Markle speak about Diana in latest Oprah interview teaser
    Harry, Markle speak about Diana in latest Oprah interview teaser
    Entertainment
  • Infinix Hot 10 Play bags BIS certification, India launch soon
    Infinix Hot 10 Play bags BIS certification, India launch soon
    Science
  • Director Amole Gupte explains trolled 'Saina' poster to 'impatient world'
    Director Amole Gupte explains trolled 'Saina' poster to 'impatient world'
    Entertainment
  • 2021 Volkswagen T-Roc SUV becomes costlier by Rs. 1.36 lakh
    2021 Volkswagen T-Roc SUV becomes costlier by Rs. 1.36 lakh
    Auto
Related Timelines
  • Delhi identifies 89 sites for COVID-19 vaccination drive: Health Minister
    Delhi identifies 89 sites for COVID-19 vaccination drive: Health Minister
    India
  • COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
    COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
    India
  • 'Finally paid off,' says Adar Poonawalla after Covishield gets approval
    'Finally paid off,' says Adar Poonawalla after Covishield gets approval
    India
  • SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
    SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
    India
Trending Topics
ISRO Vaccine Taj Mahal Jewelry Robbers
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News YouTube Hollywood News WhatsApp Bollywood News ISRO Yoga Honda Batman Football News
BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Toyota Fashion Tips Taj Mahal Mercedes
Friends Series Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers Neha Kakkar Premier League
Big Bang Theory Liverpool Chelsea X-Men
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021